Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/a2-bio-publishes-key-preclinical-findings-demonstrating-potential-of-its-highly-selective-tmod-cell-therapy-platform-to-revolutionize-the-treatment-of-solid-tumors-in-select-patients-301491139.html
https://endpts.com/a2-biotherapeutics-nabs-71m-plus-series-b-for-selective-cell-therapy-pipeline/
https://www.prnewswire.com/news-releases/a2-biotherapeutics-closes-71-5m-series-b-to-begin-clinical-development-of-its-potentially-transformative-selective-tumor-cell-therapeutics-301145221.html